These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 12753826)

  • 21. Towards an explanatory framework for national level maternal health policy agenda item evolution in Ghana: an embedded case study.
    Koduah A; Agyepong IA; van Dijk H
    Health Res Policy Syst; 2018 Aug; 16(1):76. PubMed ID: 30075722
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tuberculosis control policy in Nepal.
    Aoki M; Komatsu R
    Lancet; 1995 Oct; 346(8981):1043-4. PubMed ID: 7475582
    [No Abstract]   [Full Text] [Related]  

  • 23. The research agenda for improving health policy, systems performance, and service delivery for tuberculosis control: a WHO perspective.
    Nunn P; Harries A; Godfrey-Faussett P; Gupta R; Maher D; Raviglione M
    Bull World Health Organ; 2002; 80(6):471-6. PubMed ID: 12132005
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Reform of Japan's NTP and its technical perspectives].
    Mori T
    Kekkaku; 2004 Oct; 79(10):587-604. PubMed ID: 15631111
    [TBL] [Abstract][Full Text] [Related]  

  • 25. New strategies of tuberculosis control in the developing world.
    Enarson DA
    Pediatr Pulmonol; 2001; Suppl 23():67-9. PubMed ID: 11886153
    [No Abstract]   [Full Text] [Related]  

  • 26. The Revised National Tuberculosis Control Programme in India: time for revision of treatment regimens and rapid upscaling of DOTS-plus initiative.
    Bhargava A; Jain Y
    Natl Med J India; 2008; 21(4):187-91. PubMed ID: 19267041
    [No Abstract]   [Full Text] [Related]  

  • 27. Migration to middle-income countries and tuberculosis-global policies for global economies.
    Pescarini JM; Rodrigues LC; Gomes MG; Waldman EA
    Global Health; 2017 Mar; 13(1):15. PubMed ID: 28298223
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tackling tuberculosis in sub-Saharan Africa: EDCTP achievements and the road ahead.
    Surette MA; Beattie P; Nyirenda T; Olesen OF
    Int J Tuberc Lung Dis; 2017 Dec; 21(12):1220-1229. PubMed ID: 29297441
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Does directly observed therapy improve tuberculosis treatment? More evidence is needed to guide tuberculosis policy.
    McLaren ZM; Milliken AA; Meyer AJ; Sharp AR
    BMC Infect Dis; 2016 Oct; 16(1):537. PubMed ID: 27716104
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Towards understanding the drivers of policy change: a case study of infection control policies for multi-drug resistant tuberculosis in South Africa.
    Saidi T; Salie F; Douglas TS
    Health Res Policy Syst; 2017 May; 15(1):41. PubMed ID: 28558838
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Extreme condition, extreme measures? Compliance, drug resistance, and the control of tuberculosis.
    Harper I
    Anthropol Med; 2010 Aug; 17(2):201-14. PubMed ID: 20721757
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tuberculosis: a new vision for the 21st century.
    Small PM
    Kekkaku; 2009 Nov; 84(11):721-6. PubMed ID: 19999594
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tackling tuberculosis in Latvia.
    Zipperer M
    PLoS Med; 2005 May; 2(5):e122. PubMed ID: 15916462
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Amendment of tuberculosis prevention law and prospect of tuberculosis control program].
    Ushio M
    Kekkaku; 2005 Jul; 80(7):541-6. PubMed ID: 16167781
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Issues in pediatric tuberculosis under DOTS strategy.
    Arora VK
    Indian Pediatr; 2004 Sep; 41(9):891-3. PubMed ID: 15475629
    [No Abstract]   [Full Text] [Related]  

  • 36. [Design and semantic validation of a new instrument to assess policy transfer of directly observed treatment for tuberculosis].
    da Silva LM; Surniche Cde A; Sicsú AN; Mitano F; Nogueira Jde A; dos Santos CB; Cunha FT; Palha PF
    Rev Panam Salud Publica; 2015 Aug; 38(2):129-35. PubMed ID: 26581053
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The role of policy actors and contextual factors in policy agenda setting and formulation: maternal fee exemption policies in Ghana over four and a half decades.
    Koduah A; van Dijk H; Agyepong IA
    Health Res Policy Syst; 2015 May; 13():27. PubMed ID: 26022699
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tuberculosis deaths averted by implementation of the DOTS strategy in Kazakhstan.
    Favorov M; Belilovsky E; Aitmagambetova I; Ismailov S; White ME; Chorba T
    Int J Tuberc Lung Dis; 2010 Dec; 14(12):1582-8. PubMed ID: 21144244
    [TBL] [Abstract][Full Text] [Related]  

  • 39. DOTS and DOTS plus: what's in a name.
    Aerts A; de Haller R
    Int J Tuberc Lung Dis; 2001 Sep; 5(9):879-80. PubMed ID: 11573904
    [No Abstract]   [Full Text] [Related]  

  • 40. Beyond DOtS: avenues ahead in the management of tuberculosis.
    Chaudhury RR; Thatte U
    Natl Med J India; 2003; 16(6):321-7. PubMed ID: 14765625
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.